Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 25 of 83 entries
View as:
Phase: N/A
Priority: Normal
Start: 04/01/18
End: 09/30/19
Due: 09/30/20
Phase: N/A
Priority: Normal
Start: 03/30/25
End: 08/30/25
Due: 08/30/26
Phase: N/A
Priority: Normal
Start: 06/30/11
End: 10/31/12
Due: 10/31/13
Phase: N/A
Priority: Normal
Start: 05/19/23
End: 02/20/24
Due: 02/20/25
Phase: N/A
Priority: Normal
Start: 07/06/15
End: 08/19/15
Due: 08/19/16
Phase: N/A
Priority: Normal
Start: 08/31/07
End: 12/31/08
Due: 12/31/09
Phase: N/A
Priority: Normal
Start: 08/31/12
End: 04/30/13
Due: 04/30/14
Phase: N/A
Priority: Normal
Start: 12/31/13
End: 11/30/14
Due: 11/30/15
Phase: N/A
Priority: Normal
Start: 02/13/21
End: 12/31/26
Due: 12/31/27
Phase: N/A
Priority: Normal
Start: 11/20/17
End: 08/30/22
Due: 08/30/23
Phase: N/A
Priority: Normal
Start: 07/31/05
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 06/30/15
End: 09/30/15
Due: 09/30/16
The Effects of Expressive Writing and Compassionate Letter Writing on Emotional Distress Intolerance
Phase: N/A
Priority: Normal
Start: 07/04/21
End: 07/21/22
Due: 07/21/23
Phase: N/A
Priority: Normal
Start: 11/30/12
End: 12/31/15
Due: 12/31/16
Phase: N/A
Priority: Normal
Start: 02/29/12
End: 12/31/14
Due: 12/31/15
Phase: N/A
Priority: Normal
Start: 09/30/07
End: 12/31/07
Due: 12/31/08
Phase: N/A
Priority: Normal
Start: 05/29/19
End: 06/18/19
Due: 06/18/20
Phase: N/A
Priority: Normal
Start: 10/17/23
End: 12/31/23
Due: 12/31/24
Phase: N/A
Priority: Normal
Start: 02/28/14
End: 08/31/15
Due: 08/31/16
Phase: N/A
Priority: Normal
Start: 06/30/05
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 02/29/12
End: 09/30/15
Due: 09/30/16
Phase: N/A
Priority: Normal
Start: 01/31/12
End: 07/31/12
Due: 07/31/13
Phase: N/A
Priority: Normal
Start: 02/29/16
End: 04/30/17
Due: 04/30/18
Phase: N/A
Priority: Normal
Start: 01/31/15
End: 12/31/15
Due: 12/31/16
Phase: N/A
Priority: Normal
Start: 01/31/08
End: 09/30/08
Due: 09/30/09